Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)Mamun Al Mahtab, Morikazu Onji, E Penton et al.|PLoS ONE|2018Cited by 94
Virus-like particles as nanovaccine candidatesGerardo Guillén, Luis Gabriel González Herrera, Julio Aguilar et al.|Advances in Natural Sciences Nanoscience and Nanotechnology|2013Cited by 6